TYRA   $15.81  2.93% Market Closed After Close 15.83 0.13%

Tyra Biosciences Inc
Total Cash 373.80M
totalCashPerShare 7.088
EBITDA -95.02M
Total Debt 6.40M
quickRatio 36.187
currentRatio 36.464
Total Revenue
debtToEquity 1.702
Revenue/Share
ROA -0.18571
ROE -0.26501
grossProfits
freeCashflow -35.14M
operatingCashflow -62.96M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 535.45M
forwardPE -9.010527
floatShares 10.25M
sharesOutstanding 52.81M
sharesShort 2.20M
sharesShortPriorMonth 2.40M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.94%
Short Ratio help_outline 11.33%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 7.131
Price To Book help_outline 2.40
earningsQuarterlyGrowth
netIncomeToCommon -81.44M
trailingEps -1.73%
forwardEps -1.90%
enterpriseToEbitda -5.63
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.4 3Q 2024
institutionsCount 133
lastUpdated Nov. 7, 2024, 5:16 a.m.